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Abstract!
Background: Current clinical studies have shown that preoperative non-opioid medications are
an effective method to reduce moderate to severe pain in the postoperative settings, but are not
commonly utilized in laparoscopic cholecystectomy patients.
Purpose of this study: The purpose of this study was to evaluate the knowledge and attitudes of
anesthesia providers about the preoperative use of three different non-opioid medications:
clonidine, acetaminophen and gabapentin for the treatment of postoperative pain in laparoscopic
cholecystectomy patients.
Design: A descriptive survey research design was used to determine anesthesia providers’
knowledge and attitudes regarding preoperative non-opioid medications. A modified evidence
based knowledge and attitudes survey was administered to anesthesia providers at the
NorthShore University HealthSystem, which included physicians and nurse anesthetists.
Results: This study found that physicians and more experienced anesthesia providers had a more
positive attitude towards the use of preoperative non-opioid medications. The findings from this
study also suggested that the many anesthesia providers had a lack of knowledge regarding
gabapentin and clonidine. Based on the survey results, an educational module was developed
focusing on the gap in knowledge and attitude of anesthesia providers towards gabapentin and
clonidine as a choice of preoperative medication for postoperative pain control in laparoscopic
cholecystectomy patients.
Conclusion:!!The findings helped identify gaps in knowledge and pervasive attitudes towards
preoperative non-opioid medications among anesthesia providers to guide the development of an
educational module to address these deficiencies.
Relevance to Nursing Practice: The educational module created in this study will be useful to
increase knowledge of the use of preoperative non-opioid medications among anesthesia
providers for the management of postoperative pain in patients undergoing laparoscopic
cholecystectomy.
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Chapter 1 Introduction
Background and Significance
Postoperative pain management is an essential component of care for surgical patients.
Inadequately managed postoperative pain results in a wide variety of negative outcomes
including a decrease in alveolar ventilation and vital capacity, tachycardia, hypertension,
myocardial infarction, insomnia, poor wound healing, and delayed patient discharge from the
hospital (Harsoor, 2011). The adequacy of pain control for perioperative analgesia has
traditionally been provided by opioid analgesics, but recent studies have confirmed the negative
effects of opioid medications and suggested the use of multimodal analgesics as the new “gold
standard” to decrease these negative effects in surgical patients (Harsoor, 2011; Jakobsson,
2014). The number of patients that could benefit from non-opioid medications was potentially
quite large: For example, a multicenter trial in Canada showed that nearly 30% of patients had
moderate to severe pain 24 hours after ambulatory surgery (McGrath et al., 2004).
Minimally invasive surgery is one of the most rapidly expanding fields of surgery.
Laparoscopic cholecystectomy (LC) has become the standard of care for the treatment of
symptomatic cholelithiasis (Mitra et al., 2012). Pain after LC is common and is generally caused
by three main sources: incision sites, pneumoperitoneum resulting in diaphragmatic and
peritoneal stretching, and post cholecystectomy wounds within the liver (Mitra et al., 2012).
Improper treatment of postoperative pain can lead to complications and poor outcomes,
including longer hospital stays, higher rates of medical complications, and decreased patient
satisfaction (Morrison et al., 2003). Pain after surgery is distressing to patients, and can cause
physiological and psychological harm to them; if left unaddressed for long periods, acute pain
can become chronic pain, resulting in a significant decrease in patients’ quality of life
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(Nishimoto, 2014). Therefore, effective postoperative pain management is vital to optimize
patient care.
Pain is the most important independent predictor of recovery time in LC patients, and is
the most common postoperative symptom that can delay discharge (Mitra et al., 2012). Yet there
is little data on the optimal medications for treatment of moderate to severe pain among LC
patients. While there are several methods that can be used for postoperative pain management,
opioids are the most common (Harsoor, 2011). Though opioids are effective for rapid pain relief,
they are associated with somnolence, postoperative nausea and vomiting, constipation, and
respiratory depression, all of which can delay discharge (Mitra et al., 2012).
Clinical studies have found that the use of preoperative non-opioid medications to reduce
postoperative pain have several advantages over the use of opioids. Non-opioid medications like
acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs), alpha2 agonists (clonidine),
anticonvulsants (gabapentin), and aspirin are some of the most widely used therapeutic agents. It
has been postulated that the timing for maximum efficacy of non-opioid medications may be in
the preoperative period in order to prevent the large sensory signals that flood the central nervous
system (CNS) postoperatively (Romej, Voepel-Lewis, Merkel, & Reynolds, 1996). This
excitability may contribute to hyperalgesia postoperatively. Prevention of accumulation of
sensory signals should result in more manageable pain postoperatively (Romej et al., 1996).
While NSAIDs and aspirin are excellent in the treatment for pain, their side effect profile,
surgical contraindications, and drug interactions limit their use as preoperative medications
(Kaufman, 2010). By contrast, acetaminophen is well tolerated, has few side effects, and may
represent a better option for most patients in preoperative setting for postoperative pain
management (Kaufman, 2010). Many research articles report that oral acetaminophen has been
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shown to be safe and effective in a variety of acute pain models (Pergolizzi, Ruffa, Tallarida,
Taylor, & Labhsetwar, 2012). An important advantage of acetaminophen over other analgesic
agents is its safety and tolerability profile. In contrast to opioids, acetaminophen does not
produce sedation, respiratory depression, ileus, constipation, or substance abuse (Ofirmev, 2010).
Clonidine, an alpha-2 agonist, has been found to have potent analgesic properties without
respiratory depression, which is particularly helpful for patients who cannot tolerate the
respiratory depression caused by opioids. The analgesic effect results from alpha2adrenoreceptors located in the CNS and spinal cord; in effect, clonidine produces analgesia by
preventing pain signal transmission to the brain. In cases where opioids are still being used,
alpha2 agonists can also potentiate their analgesic effects, multiplying the impact of a given
dosage (Blaudszun, Lysakowki, Elia, & Tramèr, 2012).
Gabapentin, an anticonvulsant with analgesic effects, is another commonly used
medication for pain management in LC patients (Mitra et al., 2012). This medication produces an
analgesic effect by binding to voltage gated calcium channels and reducing neurotransmitter
release. The safety and efficacy of gabapentin has been confirmed in many trials. Other observed
benefits include reduction of movement-evoked pain, opioid sparing, and preoperative anxiolysis
(Mitra et al., 2012).
While there are several studies that assessed the efficacy of various non-opioid
medications, there is limited data on which medication is ideal for a specific surgical procedure.
In the absence of procedure specific evidence about non-opioid medications, there are many
factors that affect providers’ preferences, including institutional preference and availability,
surgeon preference, and perceived benefit based on past experience.
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Additionally, the providers’ knowledge and attitude towards the medications effect the
use of the medication. While there is no existing data on the knowledge and attitude of
anesthesia providers toward preoperative non-opioid medications in LC patients, the evidence in
favor of preoperative non-opioid analgesics raises one singular question: Why are anesthesia
providers’ at NorthShore University HealthSystem (NSUHS) not utilizing them? According to
Mitra, et al (2012), clinicians need information about the choices of preoperative medications
and their availability, to then consider these options for each type of surgery.
Problem Statement
After LC, most patients suffer from at least moderate pain (Tiippana, Bachmann, Kalso,
& Pere, 2008), which is multifactorial in origin: the incision sites, the pneumoperitoneum
resulting in diaphragmatic and peritoneal stretching, and the post cholecystectomy wound within
the liver (Mitra et al., 2012). Improved control of postoperative pain is correlated with better
patient outcomes, shorter duration of hospital stays, and improved patient satisfaction (Mitra et
al., 2012). Achieving proper pain management in these patients requires a multifaceted approach
that encompasses non-opioid medications, patient factors, and procedural complexity. As
described earlier, there are three different preoperative non-opioid medications that can safely be
used for the management of postoperative pain: acetaminophen, clonidine and gabapentin.
Anecdotal evidence suggests that anesthesia providers often use opioids postoperatively without
considering used of preoperative non-opioid medications. The reason why anesthesia providers
do not use preoperative non-opioid medications for pain in LC patients is unknown. Investigating
the knowledge and attitude of providers towards the use of non-opioid medications, specifically
acetaminophen, clonidine and gabapentin, for LCs would be beneficial.
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Purpose of Project
The purpose of this descriptive survey was to evaluate the knowledge and attitude of
anesthesia providers at NSUHS about the preoperative use of the three non-opioid medications,
acetaminophen, clonidine and gabapentin, for the management of postoperative pain in LC
patients. The findings helped identify why many anesthesia providers were not using these
medications. Using the survey results, an educational module was created to help close gaps in
knowledge, and create awareness of the utility of the use of the preoperative non-opioid
medications in LC patients.
Clinical Questions
The following clinical questions were addressed in this study:
•! What was the level of knowledge among anesthesia providers regarding the use of
preoperative non-opioid medications gabapentin, acetaminophen and clonidine for
the treatment of postoperative pain management in patients undergoing
laparoscopic cholecystectomy?
•! What was the general attitude among anesthesia providers regarding the use of
preoperative non-opioid medications gabapentin, acetaminophen and clonidine for
the treatment of postoperative pain management in patients undergoing
laparoscopic cholecystectomy?
Theoretical Framework
The conceptual framework that guided this study was the needs assessment theory, first
modeled by Roger Kaufman, who helped to evaluate the gap between the conditions and the
wants of subjects (Wright, Williams, & Wilkinson, 1998). The purpose of a needs assessment is
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to gather information about what is required to bring about a beneficial change to the health of a
population (Wright, Williams, & Wilkinson, 1998).
Stevens and Gillman (1998) explains various approaches to accomplishing a needs
assessment. The “corporate approach” involves the collection of the knowledge and attitudes of
participants, such as doctors and nurses, on healthcare services and need. The approach allows
for sensitivity to local culture and practices. This DNP project aligns with a corporate approach
to the needs assessment. Stevens and Gillman (1998) also assert that a “needs assessment is
futile if it does not result in improved services to patients (p.1451).”
Based on the needs assessment theory, a modified survey was used to evaluate the gaps in
knowledge and attitude of the anesthesia providers. An educational module was created to meet
the needs of the anesthesia providers. The knowledge and awareness provided in the educational
module may help influence anesthesia providers’ use of preoperative non-opioid medications in
LC patients, which may help guide a positive change to the overall patient outcomes.
Chapter 2 Literature Review
The following literature review discusses the three selected non-opioid medications,
acetaminophen, clonidine and gabapentin, for the use of postoperative pain management in LC
patients. A computerized literature search was completed using the following databases:
PubMed, CINAHL complete, ProQuest Nursing & Allied Health Source, and Cochrane Library.
While there was limited data available when searching for use of acetaminophen,
clonidine, and gabapentin in pain management of LC patients, the literature review indicates that
these the use of these non-opioid medications preoperative helps pain management in a variety of
other surgical procedures. Most often, medications used for one type of surgery may also work
for another surgical procedure (Toms, McQuay, Derry, & Moore, 2008). Thus, it seems likely
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that they can be used preoperatively to help in the management of moderate to severe
postoperative pain (Mitra et al., 2012).
Gabapentin
Mechanism of action/side effects. Gabapentin, a gamma-amino butyric acid (GABA)
analogue, is a widely used medication for the treatment of seizures and management of
neuropathic pain. (Bardal, Waechter & Martin, 2011). Gabapentin is an anticonvulsant that
increases the seizure threshold; it exerts its effect through selectively interacting with the α(2)δ
subunit of voltage gated calcium channels (Mikkelsen, Hilsted, Anderson, Hjortso, Enggaard,
Jorgensen, & Dahl, 2006). The side effects of gabapentin are fatigue, dizziness and ataxia
(Bardal, Waechter, & Martin, 2011).
Research. The safety and efficacy of gabapentin for pain management in a variety of
surgical procedures, such as LC includes reduction of movement-evoked pain, opioid sparing,
and preoperative anxiolysis. Gabapentin can reduce acute postoperative pain and decrease the
need for opioids. In a double-blinded randomized trial, 1.2 gm/day dose of gabapentin versus
placebo was given before and two days after coronary artery bypass graft (CABG) surgery. The
gabapentin group showed significantly lower postoperative pain scores at 1, 2, and 3 days, and
decreased consumption of tramadol as a rescue analgesic (Ucak, Onan, Sen, Selcuk, Turan, &
Yilmaz, 2012).
In 2007, Kong and Irwin published a review of the strongest available evidence
describing the safety and efficacy of gabapentin for the management of postoperative pain.
Their review included various RCTs, a systematic review, and a meta analysis. The authors
found that gabapentin reduced postoperative opioid requirements, decreased PONV, decreased
postoperative delirium and attenuation of hemodynamic response during direct laryngoscopy.
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They concluded that a single dose of gabapentin given preoperatively was useful in the
management of postoperative surgical pain. Based on their review, they recommended a single
dose of 900mg.
Ajori, Nazari, Mazloomfard, and Amiri (2012) conducted a double blind randomized trial
to evaluate the preoperative use of gabapentin on postoperative pain management, meperidine
consumption and nausea and vomiting in patients undergoing hysterectomy. Ajori et al. (2012)
found that 600!mg of gabapentin taken orally versus placebo by patients undergoing abdominal
hysterectomy significantly reduced postoperative pain and PONV, and decreased the analgesic
and antiemetic drug requirements. Gabapentin has been reported to be a well-tolerated, safe, and
effective drug given preoperatively for postoperative analgesia (Chang, Challa, Shah, & Eloy,
2014).
Pandey et al. (2004), conducted a double-blinded randomized trial where subjects were
given 300mg gabapentin, 100mg tramadol or placebo two hours before their LC surgery.
Patients’ pain was evaluated every 2 hours for the first 12 hours and then every 3 hours for the
next 12 hours. When gabapentin was compared to the placebo and tramadol group, the pain
scores were lower in the gabapentin group all the time intervals except 0-6 hours after surgery,
compared to the tramadol group. There was also a decrease in total analgesic consumption
(fentanyl) in the gabapentin group (Pandey et al., 2004). This study demonstrated the
significance of the analgesic effect of preoperative use of gabapentin (300mg) over tramadol
(100mg) or placebo for LC patients.
Amin and Amr (2011) compared the preoperative use of gabapentin and paracetamol (a
prodrug of acetaminophen) for pain control in children undergoing tonsil surgery. Tonsillectomy
is associated with significant postoperative pain, and, if treated poorly, pain can cause increased
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heart rate, blood pressure, respiratory rate, difficulty swallowing, an elevated risk of
postoperative bleeding, and prolonged hospital stay (Amin & Amr, 2011). In this double-blinded
randomized trial, 70 children underwent adenotonsillectomy and were given either gabapentin
(10mg/kg) or paracetamol (20mg/kg) two hours before induction of general anesthesia.
Postoperative pain scores were evaluated using the visual analogue scale (VAS) several hours
postoperatively. Amin and Amr (2011) concluded that gabapentin significantly decreased
postoperative pain scores compared to paracetamol, with no side effects reported.
Acetaminophen
Mechanism of action/side effects. Acetaminophen is an analgesic and antipyretic.
Acetaminophen acts on both the peripheral and central pain pathways; while there are a variety
of mechanisms of action proposed. (Pergolizzi et al., 2011). Acetaminophen most likely exerts
its effects through the inhibition of cyclooxygenase (COX) (Bardal, Waechter, & Martin, 2011).
COX helps to catalyze the formation of prostaglandins (PG) and other mediators (which are
important part in processing and signaling pain in the brain). An acute overdose (regular doses
above 4,000 mg/day) of acetaminophen can be toxic and cause hepatotoxicity. The other
associated side effect noted was increased risk for asthma (Bardal, Waechter, & Martin, 2011).
Research. The majority of current research is on the use of paracetamol (prodrug of
acetaminophen) and IV acetaminophen. Acetaminophen (paracetamol) is a familiar agent for
treating many types of pain, including post-surgical pain. Oral acetaminophen has been proven to
be effective and safe in many acute pain models (Pergolizzi, Rafffa, Tallarida, Tayor, &
Labhsetwar, 2011). Multimodal medications given with acetaminophen have revealed opioidsparing effects and therefore decreased the opioid associated side effects (Pergolizzi et al., 2011).
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A meta-analysis of seven randomized controlled trials found that acetaminophen
(including paracetamol, oral acetaminophen and IV acetaminophen) decreased the consumption
of morphine by approximately 20% in the first 24 hours after surgery (Pergolizzi et al., 2011).
Another meta-analysis (which was too diverse to perform a formal meta-analysis) of sixteen
studies and 1,464 participants found IV acetaminophen was effective across a variety of surgical
procedures for acute postsurgical analgesia (Pergolizzi et al., 2011).
In a review article Tom et al. (2008), published a review of the strongest available
evidence describing the safety and efficacy of oral paracetamol (prodrug of acetaminophen) for
the management of postoperative pain. A prodrug medication is given pharmacologically in the
inactive form and becomes active once metabolized. Their review included various RCTs, a
systematic review, and a meta analysis. Overall, the authors concluded that a single dose of
paracetamol provided effective analgesia for approximately 50% of patients with acute
postoperative pain with minimal side effects.
Clonidine
Mechanism of action/side effects. Clonidine is an alpha2 agonist that has sedative,
analgesic and anxiolytic properties. The presynaptic activation of alpha2 receptors (that inhibits
the release of norepinephrine) is believed to help mediate the analgesia (Barash, Cullen, &
Stoelting, 2006). The side effects are bradycardia and hypotension.
Research. In a review article by Lambert, Cyna, Knight, and Middleton (2014), reported
a meta-analysis of 11 relevant trials studying 742 children having surgery where premedication
with clonidine (4mcg/kg) was compared to placebo or other drug treatment. Premedication with
clonidine (4mcg/kg) had beneficial effect on postoperative pain in children. Side effects were
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minimal, though in some cases, atropine was given prophylactically with the intention of
preventing the side effect of decreased heart rate (Lambert et al., 2014).
Laisalmi, Koivusalo, Valta, Tikkanen, and Lindgren (2001) conducted a prospective
randomized controlled trial using clonidine. Preoperatively, 30 patients undergoing LC were
given either 4.5mcg/kg of clonidine or the same amount of saline (control group)
intramuscularly. Results revealed that LC patients in the clonidine group had opioid sparing
effects (50% less alfentanil was needed) along with hemodynamic stability. Postoperatively,
rescue opioids were used half as often in the clonidine group compared to the control group.
Laisalmi et al. (2001) concluded that preoperative use of clonidine was effective and the concern
about hemodynamic instability was unfounded. The results also suggested that clonidine use may
protect the kidneys from ischemic injury (Laisalmi et al., 2001).
Singh and Arora (2011) evaluated the preoperative use of clonidine in LC patients. The
researchers administered oral clonidine (150 mcg) preoperatively, which resulted in improved
perioperative hemodynamic stability, reduced intraoperative anesthetic use, and decreased
postoperative analgesic requirements. The randomized single-blinded prospective comparative
study had two groups: one was given clonidine (150mcg) and the other was given vitamin C
(100mg), both 90 minutes before induction of general anesthesia. Clonidine not only helped
blunt the cardiovascular response with insufflation of the carbon dioxide (CO2), but also the
body’s response to hypercapnia. The overall cumulative analgesic requirement in the first 24
hours was significantly lower for the group that received clonidine, and the patients benefited
from improved perioperative hemodynamic stability, reduced intraoperative anesthetic
requirements, and decreased postoperative analgesic requirements (Singh & Arora, 2011). The
authors concluded that the administration of oral clonidine (150mcg) is a simple, cost effective
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form of premedication in LC patients; it not only decreased the postoperative analgesic
requirements but also improved intraoperative hemodynamics (Singh & Arora, 2011).
A systematic review and meta-analysis of randomized controlled trials consisted of 30
studies (1,792 patients) were included. 933 of the patients received clonidine in either an IV form
or oral dose, preoperative, intraoperative or postoperative. The results concluded that alpha 2
agonist had a positive effect on hemodynamics, reduced incidence of postoperative nausea,
moderate opioid sparing postoperatively, with no evidence of lengthening recovery time
(Blaudszun et al., 2012).
Existing Knowledge and Attitude
There are several pain medication options that were trialed for LC patients, but there was
no study demonstrating the most effective medication. Evidence suggests that different
pharmacological agents including acetaminophen, clonidine and gabapentin help reduce
postoperative pain scores in patients undergoing surgical procedures, including elective LC.
Though the decision of the provider to use a specific medication must weight its benefits against
the potential side effects, the literature indicates a trend towards the use of these medications as
adjuncts to preoperative pain management in LC patients (Gurusamy, Vaughan, Toon, &
Davidson, 2014).
Although there is limited research about the knowledge and attitudes of providers on the
use of these medications for LC patients, there is data to suggest that a lack of knowledge is a
barrier to use. A study conducted by Temple, Fagerlung, and Saewyc (2005), evaluated the
knowledge, belief and assessment of herbal supplements in the anesthesia setting. They
concluded that a lack of education and limited familiarity with the supplement resulted in
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decreased usage. Following their research, the majority of the of CRNA’s requested for more
education about herbal supplements (Temple et al., 2005).
Ucuzal and Dogan (2014) performed a survey about the knowledge, attitude and clinical
decision making skills regarding pain. The survey concluded that only half the sample of nurses
believed that unrelieved pain in the emergency department increased patients’ mortality and
morbidity. Half the nurses also believed that the patients should be encouraged to withstand the
pain as much as possible before using a pain relief method. The implication of this study showed
the necessity to create education programs to help understand the attitude and lack of knowledge
about pain (Ucuza & Dogan, 2014).
Qadire and Khalaileh (2012) evaluated the knowledge and attitude among nurses
regarding pain management in cancer patients. This study stated that 50% of healthcare providers
lacked knowledge about pain assessment and management, including information about
medications. The overall study found that the nurses did not have enough knowledge to treat
patient’s pain. This demonstrated the need for continuing pain management education in
hospitals (Qadire & Khalaileh, 2012).
Matthews and Malcolm (2007) aimed to evaluate the knowledge and attitude of nurses
after a knowledge and competency program about orthopedic pain management. One group of
nurses received the training program and the other group did not. The study concluded that the
overall score was much better (73.8%) for the nurses that received the program. Matthews and
Malcolm (2007) recommended continued mandatory training for nurses in pain management.
A significant body of research supports the use of acetaminophen, clonidine and
gabapentin for pain management, even though there is limited research about the use of these
specific medications for LC patients. Some studies evaluated the knowledge and attitudes of
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healthcare workers about pain management, although there is limited data for these specific nonopioid medications. More specifically, there is even more limited data available about anesthesia
providers’ knowledge and attitudes about these specific non-opioid analgesics for LC patients.
This study aimed to fill the gap in knowledge regarding preoperative use of non-opioid
medications in LC patients to anesthesia providers.
Chapter 3 Methods!
Research Design
A descriptive survey design was used to gain an understanding of the clinical knowledge
and attitude of anesthesia providers at NHUHS with regard to the preoperative use of non-opioid
medications for the management of postoperative pain in LC patients. Based on the results, an
education module was developed to focus on the gaps identified in the anesthesia providers’
knowledge of the medications.
Target Audience
The group of anesthesia providers that were invited to take part in the survey were also
the target audience of the educational module.
Sample
The study’s sample consisted of a convenience sample of anesthesia providers employed
at NSUHS. Inclusion criteria include all anesthesia provider at NorthShore University.
Exclusion criteria included nurse anesthesia students (SRNAs), residents and medical students.
Sample size. The Department of Anesthesiology at NSUHS consists of 70 anesthesia
providers. A response rate of at least 40% was desired, yielding a proposed target sample size of
28 participants. Though Sivo, Saunders, and Chang (2006) found a response rate of 70% is very
good and 60% is good, the authors found that actual response rates of surveys were around 30%.
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However, the average response rate was 40% in 4 out 6 journals that were surveyed (Sivo,
Saunder, & Chang, 2006).
Setting
The study was conducted among anesthesia providers employed at NSUHS, which is a
large health care system consisting of four hospitals and provides a full range of healthcare
services in the northern suburbs of Chicago. Among the four facilities, there is a large variety of
surgical specialties, ranging from minimally invasive procedures to open heart surgery, including
approximately 1,000 laparoscopic cholecystectomies per year.
Instrument
The study survey (Appendix A) consisted of two parts: a demographic and background
practice information section and a section assessing the knowledge and attitude associated with
the preoperative use of the non-opioid medications. The second section was modeled from a
survey conducted by Temple et al. (2005), which assessed the knowledge and beliefs of Certified
registered nurse anesthetists regarding herbal supplements.
The knowledge and beliefs survey developed by Temple et al. (2005) was developed
alongside two doctorate nursing faculty, a CRNA educator and a nurse researcher. The survey
was evaluated for content validity, readability and internal consistency (Cronbach α, 0.82);
validity was verified by exploring the positive correlation between the survey and knowledge
and beliefs (Temple et al., 2005).
The knowledge and attitude items used in this study were modified from the Temple
survey to be more applicable to the non-opioid medications, acetaminophen, clonidine and
gabapentin. It was reviewed by 6 anesthesia providers (anesthesiologists and CRNAs) for clarity

MANAGEMENT OF POSTOPERATIVE PAIN: CREATION OF MODULE

20

and appropriateness. This modified knowledge and attitude survey was formed with a good
internal consistency (Cronbach α, 0.79).
The survey consisted of 21 questions. Four demographic questions addressing age,
gender, experience and type of anesthesia provider. Three questions were asked to better
understand how the anesthesia providers “routinely” practiced. Five knowledge and seven
attitude question were asked along with two questions regarding how likely the anesthesia
provider felt to recommend non-opioid medications to their patients. For the knowledge and
attitude items, responses were rated on either a five-point Likert-type scale, ranging from one to
five (1-strongly disagree, 2=disagree, 3=neutral, 4=agree, 5=strongly agree) or a four-point
Likert-type scale, ranging from one to four (1=regularly, 2=occasionally, 3=rarely, 4=never).
The two recommendation questions were also rated on a four-point Likert-type scale.
The survey was formatted for electronic distribution and collection using the Qualtrics
software provided by DePaul University.
Recruitment of Subjects
Before the study was initiated, approval was obtained by the institutional review boards
(IRB) from DePaul University and NorthShore University HealthSystem. Copies of IRB
approval can be found in Appendix B. A recruitment e-mail (Appendix C) was sent to the
anesthesia providers by one of the clinical coordinators, Julia Feczko, CRNA, DNP. The
recruitment e-mail contained the purpose of the study and the inclusion/exclusion criteria. An
information sheet for participation (Appendix D) was sent to further explain the nature of the
study, its anonymous and voluntary nature and the implied consent. By nature of it being a
survey, completion of survey implied consent to participant. Those anesthesia providers at
NSUHS who met the inclusion criteria were directed to open the Qualtrics link to the online
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survey. The survey was distributed via an e-mail link and used the Qualtrics system. Completion
of survey was estimated to take no more than 10 minutes.
Data Collection and Analysis
Survey responses were first collected and assessed in Qualtrics for completeness and
inclusion/exclusion criteria. Qualtrics allows data to be automatically anonymized and then
exported for analysis into Excel spreadsheets and the Statistical Package for the Social Sciences
software version 22 (SPSS) program. The SPSS was used to analyze the collected data.
Demographic variables and key responses were entered into SPSS descriptive statistics to
determine frequencies, mean and standard deviation. Data was further analyzed using the fisher
exact test and t-test to determine statistical significance.
Protection of Human Subjects
Collaborative Institutional Training Initiative (CITI) and Financial Conflict of Interest
(FCOI) certifications (Appendix E), ensuring the researcher’s understanding of what constitutes
research and how human subjects must be protected in studies, were completed in December
2014. Upon completion of the modules, the DePaul University IRB and NorthShore University
HealthSystem IRB reviewed the study. Once approved, the recruitment e-mail, information sheet
for participation, and the link to the survey on Qualtrics was e-mailed to the anesthesia providers
via the clinical coordinator at NSUHS, Evanston location. Qualtrics survey link assured no
participant identifiers were collected when completing the survey. To ensure anonymity, no links
could be tied between the subjects and the researcher.
The participation of the subjects was voluntary and there were no repercussions for
deciding not to complete the study. The identity of participants remained anonymous, with
supervisors having no access to the information, and participation having no effect on
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employment status. There was no direct benefit for the study subjects for their participation in
research project. Knowledge gained from this study could be used solely to produce benefits to
the anesthesia profession and patient care.
Chapter 4 Results
In this chapter, data results are discussed including the sample and the responsible
provider, knowledge of each of the medications, attitudes toward each of the medications, overall
association between the knowledge and attitude of acetaminophen, clonidine and gabapentin and
the consideration of the use of the medications. The results were used by the study investigator to
develop an educational module to provide information to enhance the use of the three indented
preoperative non-opioid medications, ultimately to help bridge the gap between the knowledge
and attitudes among anesthesia providers (Appendix F).
Description of Sample
The survey was distributed to a total of 70 participants at NSUHS. A total of 33
participants completed the survey for a 47% response rate. The age of the participants ranged
from 30 to >59 years. The majority of participants were female (n=23, 70%) CRNAs (n=24,
73%). Most participants had been providing anesthesia for >20 years (n=15, 46%). There were
too few participants in each age group to allow for the study to yield statistically significant
results at the sub-group level, see Table 1.
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Table 1. Description of Sample
VARIABLES
(N=33)
AGE

GENDER
PRACTIONER
TYPE
YEARS OF
PRACTICE

FREQUENCY

NUMBER (N)

PERCENT (%)

20-29
30-39
40-49
50-59
≥59
Male
Female
Anesthesiologist
CRNA
1-3
4-6
7-10
11-15
16-20
>20

0
9
9
12
3
10
23
9
24
6
3
2
5
2
15

0%
27%
27%
36%
9%
30%
70%
27%
73%
18%
9%
6%
15%
6%
46%

Background Practice Information on Mangement of Preoperative Pain
The participants were asked which anesthesia providers was usually responsible for
obtaining preoperative anesthetic evaluations for patients (survey question 5). The respondents
were able to choose multiple answers for this survey question. 52% (n=30) of participants
reported it being the anesthesiologist’s repsonsibility. 34% (n=20) of participants reported it was
the CRNA’s responsibilty. 14% (n=8) indicated the “other” option which included the SRNA
and anesthesiology resident.
The participants were asked which anesthesia providers were usually responsible for
planning/discussing postoperative pain management with the patient (survey question 6). This
survey question could be answered with multiple answers. 56% (n=28) of participants reported it
being the anesthesiologist’s repsonsibility to plan/discuss postopertive pain management with
patients. 28% (n=14) of participants reported it was the CRNA’s responsibilty. 14% (n=8)
indicated the “other” option which included the SRNA, resident, or surgeon, see Table 2.
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Table 2. Responsibilty of Preop Evaluation and Planning/Discussing Postoperative Pain
Responsible for Obtaining
Preoperative Evaluations
N
(%)
Anesthesiologist
CRNA
Other

30
20
8

52
34
14

Responsible for Plan/Discus
Postoperative Pain with Patient
N

(%)

28
14
8

56
28
14

The participants were asked how often they ordered non-opioid medications
preoperatively for postoperative surgical pain management (survey question 7). The four-point
Likert scale was ranging from 1= never, 2=regularly, 3=occasionally, to 4= regularly. 21% (n=7)
of the participants answered they regularly ordered non-opioid pain medications preoperatively
for management of postoperative surgical postoperative pain. 30% (n=10) indicated they
occasionally ordered non-opioid pain medications; these two groups represented 51% of the
participants. 30% (n=10) of the participants indicated rarely and 18% (n=6) indicated they never
ordered non-opioid pain medications for surgical postoperative pain management; these two
groups represented 48% of participants. The mean (out of 5) and standard deviation (2.45
and1.03) implied the average participant reported occasionally or rarely ordering non-opioid
medications preoperatively for postoperative surgical pain management, see Figure 1.
Figure 1. Frequency of anesthesia providers ordering non-opioid medications
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Knowledge of Anesthesia Providers
Confidence in knowledge regarding non-opioid preoperative medications. In order to
assess the anesthesia providers’ knowledge about the preoperative non-opioid medications, the
participants were asked about their confidence in their knowledge base regarding the
preoperative administration of acetaminophen, clonidine and gabapentin for the management of
postoperative pain in patients undergoing LC (survey question 8). The five-point Likert scale
ranging from 1= strongly agree to 5 = strongly disagree was used to measure knowledge related
questions in this study. 48% (strongly agree, n=2; agree, n=14) expressed that they were
confident in their knowledge regarding these non-opioid medications. 24% (n=8) of participants
were neutral. 27% (disagree, n=8; strongly disagree, n=1) did not feel confident in their
knowledge base. The mean and standard deviation (2.76 and 1.00) indicated that the average
anesthesia provider was neutral in his or her knowledge regarding the administration of
acetaminophen, clonidine, and gabapentin for the management of postoperative pain in LC
patients, see Figure 2
Figure 2. Confidence in Knowledge base:

Desire for educational opportunities. The participants were asked about their desire for
more educational opportunities regarding the administration of preoperative non-opioid
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medications (acetaminophen, clonidine and gabapentin) for the management of postoperative
pain in LC patients (survey question 9). 85% (strongly agree, n=7; agree, n=21) expressed a
desire for more education regarding these medications. 15% (n=5) of participants were neutral
and none responded disagree or strongly disagree. The mean and standard deviation (1.94 and
0.61) indicated that average participant desired more education regarding the use of
acetaminophen, clonidine and gabapentin preoperatively for LC patients, see Figure 3.
Figure 3. Desire for Education:

Specific knowledge about preoperative non-opioid medications. In order to evaluate
the participants’ knowledge about the individual medications, they were asked about their
familiarity with side effects, indications, and possible anesthetic implications (survey questions
14-16), see Figure 4.
Regarding acetaminophen, 97% (strongly agree, n=14; agree, n=18) of participants
indicated familiarity, 3% (n=1) were neutral with the side effects, indications, and possible
anesthetic implications. None of the participants indicated unfamiliarity with the medication. The
mean value for the knowledge base of acetaminophen was 1.61/5 with a SD of 0.56, which
suggested that average anesthesia provider was strongly familiar with this medication.
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Regarding clonidine, 61% of participants indicated familiarity (strongly agree, n=2;
agree, n=18), 18% were neutral (n=6), and 21% were unfamiliar (disagree, n=7; strongly
disagree, n=0) with the side effects, indications and anesthetic implications. The mean value for
the knowledge base of clonidine was 2.55/5 with a SD of 0.90, which suggested that average
participant felt neutral or familiar with the drug.
Regarding gabapentin, 49% (agree, n=16) of participants indicated familiarity, 24% were
neutral (n=8), and 27% were unfamiliar (disagree, n=9; strongly disagree, n=0) with the side
effects, indications, and anesthetic implications. The mean value for the knowledge base of
gabapentin was 2.79/5 with a SD of 0.86, which suggested that average anesthesia provider felt
neutral or familiar with the drug.
From this data, it can be concluded that, while anesthesia providers’ level of knowledge
regarding acetaminophen was strong, this was not the case for clonidine and gabapentin.
Figure 4. Knowledge of the Medications
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Attitude of Anesthesia Providers
In order to assess the participants’ attitude about preoperative administration of nonopioid medications for the purpose of postoperative pain management, they were asked to
indicate their impression of acetaminophen, clonidine and gabapentin (collectively) in having a
positive impact on surgical outcomes, postoperative pain and overall patient outcomes in LC
patients (survey questions 10-12). The five-point Likert scale ranging from 1= strongly agree to
5 = strongly disagree was used to measure attitudes, see Figure 5.
The participants were asked about the use of acetaminophen, clonidine and gabapentin
for positive surgical outcomes (survey question 10). 79% of participants (strongly agree, n=4;
agree, n=21) expressed that these medications had positive surgical outcomes; 22% (n=7) of
participants were neutral. None of the participants expressed a negative attitude. The mean and
standard deviation (2.09, 0.59) indicated that on average the participants agreed that the
medications had a positive impact on surgical outcomes by helping manage postoperative pain in
LC patients.
The participants were asked about the use of acetaminophen, clonidine and gabapentin
for postoperative pain management (survey questions 11). 91% (strongly agree, n=6; agree,
n=24) of participants indicated the medications had a positive impact on postoperative pain; 9%
(n=3) felt neutral. None of the participants expressed a negative attitude. The mean and standard
deviation (1.91, 0.52) indicated that on average the participants agreed that the medications had a
positive impact on postoperative pain mangment in LC patients.
The participants were asked about the use of acetaminophen, clonidine and gabapentin on
overall patients outcomes (survey question 12). 82% (strongly agree, n=6; agree, n=21) of
participants indicated the medications had positive overall patient outcomes, and 18% (n=6) felt
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neutral. None of the participants expressed a negative attitude. The mean and standard deviation
(2.00, 0.61) indicated that the on average the participants agreed that the medications had a
positive overall outcome for LC patients.
Figure 5. Attitude towards the Medications

The anesthesia providers were asked whether they would consider using acetaminophen,
clonidine and gabapentin (collectively) preoperatively specifically for LC patients (survey
question 13). 88% (strongly agree, n=8; agree, n=21) expressed they would consider doing so,
and 12% (n=4) participants felt neutral. None of the participants indicated negatively. The mean
and standard deviation (1.88, 0.60) indicated that on average the participants agreed to consider
the preoperative administration of acetaminophen, clonidine and gabapentin for LC patients.
In order to assess the anesthesia providers’ attitude about the preoperative use of nonopioid medications, the participants were then asked about the use of each of the specific nonopioid medications, individually (acetaminophen, clonidine and gabapentin) (survey questions
17-19). The four-point Likert scale ranging from 1=regularly, 2=occasionally, 3=rarely, 4=
never, was used in this section, see Figure 6.
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Regarding acetaminophen, 63% (regularly, n=9; occasionally, n=12) of participants used
this medication for postoperative pain management in patients undergoing LC; 36% (n=12)
reported rarely doing so. None of the participants reported never using the medication. The mean
and standard deviation (2.09, 0.80) suggested that the average participant occasionally used
preoperative acetaminophen for postoperative pain management in LC patients.
Regarding clonidine, 3% (n=1) of participants occasionally used this medication for
postoperative pain management in patients undergoing LC; 97% (rarely, n=5; never, n=27) of the
participants tend not to use the medication. None of the participants indicated they regularly used
it. The mean and standard deviation (3.79, 0.48) suggested that the average participant rarely or
never used preoperative clonidine for postoperative pain management in LC patients.
Regarding gabapentin, 9% (regularly, n=1; occasionally, n=2) of participants used this
medication for postoperative pain management in patients undergoing LC; 91% (rarely, n=5;
never, n=25) tended not to use the medication. The mean and standard deviation (3.64, 0.74)
suggested that the average participant rarely or never used preoperative gabapentin for
postoperative pain management in LC patients.
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Figure 6. Use of Medications

Recommendation of Administration
Participants were asked if they recommended or discouraged the administration of
acetaminophen, clonidine and gabapentin preoperatively for the management of postoperative
pain in LC patients (survey questions 20-21). 48% of participants regularly (n=3) or occasionally
(n=13) recommend administration of these non-opioid medications preoperatively, while 52% of
participants would rarely (n=10) or never (n=7) do so. The mean and standard deviation (2.64,
SD 0.93) suggested that the average participant rarely to occasionally recommended the use of
these medications preoperatively.
On the other hand, 97% of participants stated they would never (n=23) or rarely (n=9)
discourage the administration of these medications, and only 3% of participants would
occasionally (n=1) discourage the administration. The mean and standard deviation (3.67, 0.54)
suggested that the average participant rarely to never discouraged the use of these medications.
Association between Knowledge and Use of Acetaminophen, Clonidine & Gabapentin
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The mean scores of the knowledge and use of acetaminophen, clonidine and gabapentin
are represented in Table 4. Anesthesia providers’ indicated a strong knowledge base for the use
of acetaminophen and also reported higher use of acetaminophen preoperatively. Conversely,
providers felt neutral or agreed to have a familiarity with the side effects, indications, and
anesthetic implications of the clonidine and gabapentin, and likewise reported lower use of these
medications preoperatively for LC patients.
Table 4. Knowledge and Use of Medications:
N = 33
Clonidine
Gabapentin
Acetaminophen

Knowledge of Medication
Mean
2.55
2.79
1.61

Use of Medication
Mean
3.79
3.64
2.09

Knowledge and Attitude related to Demographics
The fisher exact test was used as an alternative to the chi-square test because of the small
sample size. This yielded a more accurate test compared to the chi-square test for the knowledge
and attitude survey results. The demographic variables assessed in this section included gender
(male, female), provider type (anesthesiologist, CRNA), years of experience (1-15, ≥16), and age
(20-49, ≥50). Because of the small sample size, the years of experience and age categories were
collated into two sub-sets each.
Knowledge. The age, gender, provider type, and years of experience did not have a
statistically significant association with the knowledge of clonidine, gabapentin and
acetaminophen.
Attitude. The t-test was used to determine the differences in participants’ attitudes based
on demographic variables. For age, participants in the ≥50 years age group scored significantly
higher than the participants between the ages of 20-49 (t=2.25, df=28, P=.032); however, the
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mean difference of 3.1/5 (SD 3.8) for ≥50 age group was similar to the the mean for the ages of
20-49 age group of 3.1/5 (SD 3.75).
Regarding experience, participants with ≥16 years in practice were significantly more
likely to have a positive attitude towards using the medications preoperatively than participants
with 1-15 years of experience (t=2.65, df=28, P=.013)
With regard to role of the participant, anesthesiologists had a more positive attitude about
the use of the medications than CRNAs and this was near statistical significance (t=-1.96, df=28,
P=0.06). There was no statistical correlation between demographics and gender.
Chapter 5 Discussion
Pain relief after CL is an issue of great importance, as inadequately managed
postoperative pain results in a wide variety of negative outcomes, including impaired ventilation,
adverse hemodynamic responses, poor wound healing, and delayed patient discharge from the
hospital (Harsoor, 2011). It is the duty of anesthesia providers to care for these patients and
attempt to reduce postoperative pain safely and effectively. A multimodal approach, including
non-opioid medications started in the preoperative period appears to be a key strategy to decrease
postoperative pain and decrease overall opioid consumption (Smith, 2011). Three non-opioid
medications have been employed for preoperative use for the management of postoperative pain:
acetaminophen, clonidine and gabapentin.
A survey was sent to evaluate NSUHS anesthesia providers’ knowledge and attitude
regarding the use of these non-opioids in the preoperative setting for the treatment of
postoperative pain in LC patients. 73% of the surveys were completed by CRNAs and 26% of
the surveys were completed by anesthesiologists. The participants’ responses indicated that they
lacked knowledge regarding the clonidine and gabapentin; 85% indicated that they desired
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educational opportunities on the topic, 15 % were neutral, and no one indicated that they did not
desire additional education. Overwhelmingly, the results showed that participants had a positive
attitude towards the use of the medications preoperatively, indicating that they understood its
usefulness in contributing to positive patient outcomes.
When asked about the three medications, collectively, only 48% of anesthesia providers
reported confidence in their knowledge base regarding their use for the management of
postoperative pain in LC patients. As noted in the Temple study (2005), lack of education and
limited familiarity with the substances resulted in decreased usage. This may explain why only
50% of anesthesia providers routinely ordered non-opioid pain medications preoperatively for
postoperative pain management.
When asked about each medication, separately, providers reported strong knowledge
regarding acetaminophen and higher use of acetaminophen. They reported lower knowledge of
clonidine and gabapentin and, correspondingly, lower use of these medications. The
investigator’s results mirrored Temple’s results, indicating that knowledge of the medication is
positively correlated with use, and lends credibility to the idea that an educational module
created specifically to improve the knowledge of the anesthesia providers towards the use of
clonidine and gabapentin in LC patients would be beneficial in increasing preoperative nonopioid medication use.
The study’s small sample size precluded the ability to draw strong conclusions about
knowledge base or use for specific sub-populations. Using the fisher exact test given the limited
sample size, the study found no correlation between anesthesia providers’ gender, age, type of
provider (CRNA vs anesthesiologist) and experience on their knowledge of preoperative nonopioid analgesic agents including clonidine, gabapentin and acetaminophen.

MANAGEMENT OF POSTOPERATIVE PAIN: CREATION OF MODULE

35

A statistically significant relationship was found between the anesthesia providers’ age
and attitude towards the medications was found: anesthesia providers over 50 years old had a
more positive attitude towards the use of the medications in the preoperative setting compared to
younger providers (ages 20-49). This relationship can be due to the lack of knowledge and years
of experience. The older providers, tended to have more experience and knowledge which could
be the reason for the positive attitude. There was also a (highly related) statistical significance
between attitude and years of experience: providers with more than 16 years of experience
showed a more positive attitude about preoperative medications.
There was near significance when analyzing anesthesia provider type, as
anesthesiologists were more likely to have positive attitudes towards the use of the preoperative
non-opioid medications than CRNAs. Interesting to note, in evaluating “routine” practices
among the group, anesthesiologists were more frequently indicated to be responsible for
planning and discussing postoperative pain management with the patients. The difference in
attitude towards the use of the medications preoperatively may be explained by the inherent
challenges associated with the CRNA/anesthesiologist supervisory nature, including “diffusion
of responsibility”. Diffusion of responsibility in this case may find the CRNA relinquishing
responsibility, expecting the anesthesiologist to take the lead role, (Falke, Lawson, Pandit, &
Patrick, 2015).
The findings indicated that an educational module must focus more specifically towards
younger anesthesia providers, newer anesthesia providers, and CRNAs to improve their
knowledge base and their comfort with the use of the non-opioid medications in the preoperative
setting. Additionally, the findings indicated that the module should focus on clonidine and
gabapentin, as the providers indicated knowledge and use of acetaminophen.
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Educational Module
The educational module was created based on the assessment needs of the participants.
The results indicated there was a gap in the knowledge of anesthesia providers about the use of
clonidine and gabapentin preoperatively in LC patients; despite the clear potential benefits that
are identified in current literature.
While different learning styles of the target audience was considered, the educational
module was created in a one-page word document in order to deliver clear and concise
information to anesthesia providers. It contains information about clonidine and gabapentin. The
information included in the module contains: the mechanism of action, causes of the
medications, dose range, most common dose range, the authors recommendation of dose, timing,
benefits, side effects and anesthetic considerations. The articles used were by Blaudszun et al.,
2012 and Kong et al., 2007. These articles were described above in the literature review and if
further information is desired, the reader can refer to PubMed.
The educational module may be distributed to the target audience individually and placed
on the intranet for easy access. High level evidence, in the form of systematic review and meta
analysis, were chosen as references. The format of the module was a summary of the research
articles, highlighting the medications’ mechanism of action, dose ranges, usual dose, frequency
and timing, side effects and anesthetic considerations. The medications were presented side by
side. The module was created to increase awareness of the two medications for the use in LC
patients.

Limitations
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A limitation of this study was its small sample size. This limited the ability to examine
specific relationships amongst sub-groups and resulted in a small power to the study. A larger
sample size might have better guaranteed that the educational module was generalizable to the
other anesthesia departments. Because the target population only consisted of one employer
(NorthShore University HealthSystem), the results may not be generalizable to other
organizations.
The anesthesia providers were asked to stratify their knowledge on a Likert scale based
survey, which could have created an inherent bias just as any other survey. Anesthesia providers
may not have provided accurate answers resulting in an inaccurate educational module. Thus,
conducting in-depth interviews with anesthesia providers would be an appropriate method to
provide insight into the educational module. However, the data on the educational module would
still have a benefit.
Direction for Future Research
Implementation. Implementation of the educational module should begin with a
discussion with the Chair of the Anesthesia Department and the Chief CRNA in order to plan for
optimal dissemination among the group. Face to face presentations would be scheduled and
announced to the group for the purpose of introducing the educational module and allowing for a
question and answer session. Following that, the educational module would be placed and
posted in strategic places to serve as a reference guide. Suggested places include the break
rooms, individual interoffice mailboxes, laminated and secured to each anesthesia Pyxis
machine. Ideally, the educational module would be place on EasyCall, the intranet/paging system
utilized by NSUHS for easy access).
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Evaluation. In order to evaluate if the educational module resulted in a change in
practice, various evaluations may be conducted. First, at approximately six months after
dissemination of the module, a survey could be distributed to the group asking about their use of
gabapentin and clonidine preoperatively for postoperative pain in LC patients. At one-year post
dissemination of the module, a retrospective study could be performed to evaluate the use of
preoperative gabapentin and clonidine in LC patients. This may pave the way to a randomized
control trial to truly evaluate the efficacy of the use of preoperative non-opioid medications
directly in LC patients.)
Chapter 6 Conclusion
This study designed to evaluate the knowledge and attitude of anesthesia providers at
NSUHS about the preoperative use of the three non-opioid medications, acetaminophen,
clonidine and gabapentin, for the management of postoperative pain in LC patients. The results
from this study revealed that many anesthesia providers did not routinely use these medications
preoperatively for the management of pain after laparoscopic cholecystectomy due to lack of
knowledge and negative attitudes. Additionally, younger anesthesia providers and CRNAs had a
less favorable attitude towards the use of the medication preoperatively, than their counterparts.
Less favorable attitudes may stem from lack of education regarding the use of acetaminophen,
clonidine and gabapentin preoperatively. Based on the survey results, an educational module
was created to increase the knowledge of the medications, as well as raise awareness for the use
of the medications preoperatively for the management of postoperative pain in laparoscopic
cholecystectomy patients.
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Preoperative Non-opioid Medications for the Management of
Postoperative Pain:
Knowledge and Attitude Survey
Section 1. Demographic Questions
What is your age?
a.! 20-29
b.! 30-39
c.! 40-49
d.! 50-59
e.! >59
What is your gender?
a.! male
b.! female
What is your role (job title)?
a.! Anesthesiologist
b.! CRNA
How many years have you been practicing anesthesia in this role?
a.! 1-3
b.! 4-6
c.! 7-10
d.! 11-15
e.! 16-20
f.! >20
Who is usually responsible for obtaining preoperative anesthetic evaluations at NorthShore
University HealthSystem? (Please choose all that apply)
a.! Anesthesiologist
b.! CRNA
c.! Other, please explain________________________________
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Who is usually responsible for for planning/discussing postoperative pain management
with the patient? (Please choose all that apply)
a.! Anesthesiologist
b.! CRNA
c.! Other, please explain________________________________
How often do you order non-opioid medications preoperatively for the management of
postoperative surgical pain?
REGULARLY

OCCASIONALLY

RARELY

NEVER

Section 2. Knowledge and Attitudes
Directions: Please answer the following questions designed to assess your knowledge and
attitude regarding the use of non-opioid medications preoperatively for the management of
postoperative pain in patients undergoing laparoscopic cholecystectomy.
Answer the following questions on a scale of 0 = Strongly Disagree to 5 = Strongly Agree.
I feel confident in my knowledge base regarding the administration of non-opioid medications
preoperatively (specifically, clonidine, gabapentin, and acetaminophen) for the management of
postoperative pain in patients undergoing laparoscopic cholecystectomy.

!
I would like more educational opportunities regarding the administration of non-opioid
medications preoperatively (specifically, clonidine, gabapentin, and acetaminophen) for the
management of postoperative pain in patients undergoing laparoscopic cholecystectomy.

!
Administration of non-opioid medications preoperatively (specifically, clonidine, gabapentin,
and acetaminophen) for the management of postoperative pain in patients undergoing
laparoscopic cholecystectomy CAN have a positive impact on surgical outcomes.

!

!
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Administration of non-opioid medications preoperatively (specifically, clonidine, gabapentin,
and acetaminophen) for the management of postoperative pain in patients undergoing
laparoscopic cholecystectomy CAN have a positive impact on postoperative pain.

!
Administration of non-opioid medications preoperatively (specifically, clonidine, gabapentin,
and acetaminophen) for the management of postoperative pain in patients undergoing
laparoscopic cholecystectomy CAN have a positive impact on overall patient outcomes.

!
Administration of non-opioid medications preoperatively (specifically, clonidine, gabapentin,
and acetaminophen) for the management of postoperative pain should be considered for patients
undergoing laparoscopic cholecystectomy.

Please apply the following statement to the next three questions.!
I am familiar with the indications, side effects, and possible anesthetic implications of the
following non-opioid medications.
Clonidine

Gabapentin

Acetaminophen

!

!

!
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Please answer the remaining questions using the scale: Regularly, Occasionally, Rarely &
Never.
Apply the following statement to the next three questions:
I personally use the following non-opioid medications preoperatively for the management of
postoperative pain in patients undergoing laparoscopic cholecystectomy:
Clonidine
REGULARLY

OCCASIONALLY

RARELY

NEVER

OCCASIONALLY

RARELY

NEVER

OCCASIONALLY

RARELY

NEVER

Gabapentin
REGULARLY

Acetaminophen
REGULARLY

I recommend the administration of non-opioid medications preoperatively (specifically,
clonidine, gabapentin, and acetaminophen) for the management of postoperative pain in patients
undergoing laparoscopic cholecystectomy to others.
REGULARLY

OCCASIONALLY

RARELY

NEVER

I discourage the administration of non-opioid medications preoperatively (specifically,
clonidine, gabapentin, and acetaminophen) for the management of postoperative pain in patients
undergoing laparoscopic cholecystectomy.
REGULARLY

OCCASIONALLY

RARELY

NEVER
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Dear anesthesia providers.
My name is Pooja Mehta, RN, BSN. I am a doctoral student at DePaul University and the
NorthShore University HealthSystem School of Nurse Anesthesia. You are receiving this email
to ask for your participation in my doctoral project. Participation in this survey includes the
following criteria: licensed and employed anesthesia providers at NorthShore University
HealthSystem who are providing anesthesia to laparoscopic cholecystectomy patients. The study
will include attending physicians, both MD and DO, that have anywhere from 1-30 years of postresidency training. Certified Registered Certified Nurse Anesthetists (CRNA) will also be
present with anywhere from 1-30 years of postgraduate experience.
The goal of this survey is to determine your knowledge and attitude about the use of
preoperative, non-opioid analgesics in laparoscopic cholecystectomy patients. Your time is
valuable, and this survey will take less than 10 minutes to complete. Attached is an information
sheet describing the voluntary and anonymous nature of this survey. Completion of the survey
implies voluntary agreement to participate in the survey. Your input is greatly appreciated and I
thank you in advance for your participation.
If you have questions about this study please contact Pooja Mehta at pnmehta1128@gmail.com
or 562-818-7484.
Again thank you in advance for your time and participation.
!
!
!
!
!
!

Survey!Website:!!https://depaul.qualtrics.com/ControlPanel/!
!

Pooja Mehta, RN BSN
NorthShore University HealthSystem
School of Nurse Anesthesia
!

MANAGEMENT OF POSTOPERATIVE PAIN: CREATION OF MODULE

Appendix D
Information Sheet for Participation

55

MANAGEMENT OF POSTOPERATIVE PAIN: CREATION OF MODULE

56

INFORMATION SHEET FOR PARTICIPATION IN RESEARCH STUDY
THE ATTITUDE AND KNOWLEDGE OF ANESTHESIA PROVIDERS ABOUT NON-OPIOID
PREOPERATIVE PAIN MEDICATIONS FOR LAPAROSCOPIC CHOLECYSTECOMY
PATIENTS
Principal Investigator: Pooja N Mehta, RN BSN
Institution: DePaul University, USA
Faculty Advisor: Susan Krawczyk, CRNA, DNP. Faculty NorthShore University HealthSystem
Collaborators: Julia Feczko, DNP, CRNA. Staff NorthShore University HealthSystem
Young-Me Lee, PhD, RN. Assistant Professor DePaul University
I am conducting a research study, because I am trying to learn more about the knowledge and attitude of
anesthesia providers about the preoperative use of the three different non-opioid medications: clonidine,
gabapentin, and acetaminophen for the management of postoperative pain in laparoscopic
cholecystectomy patients. I am asking you to participate in the research because you are a licensed and
employed anesthesia provider, working at NorthShore University HealthSystem, and provide anesthesia
to laparoscopic cholecystectomy patients. You are included if you are an attending physicians, both MD
and DO, that have anywhere from 1-30 years of post-residency training. Certified Registered Certified
Nurse Anesthetists (CRNA) will also be present with anywhere from 1-30 years of postgraduate
experience.
If you agree to be in this study, you will be asked to complete a 10 minute anonymous survey. The
survey will include demographic questions along with questions about preoperative pain management in
laparoscopic cholecystectomy patients. The survey includes questions about clonidine, gabapentin, and
acetaminophen. I will also collect some personal information about you such as your title, gender, age
group, and number of years practicing anesthesia. If there is a question you do not want to answer, you
may skip it.
This study will take about 10 minutes of your time. Research data collected from you will be anonymous.
Your participation is voluntary, which means you can choose not to participate. There will be no negative
consequences if you decide not to participate or change your mind later after you begin the study. You
can withdraw your participation at any time prior to submitting your survey. If you change your mind
later while answering the survey, you may simply exit the survey. Once you submit your responses, I will
be unable to remove your data later from the study because all data is anonymous and I will not know
which data belongs to you. Your decision whether or not to be in the research will not affect your
employment at NorthShore University HealthSystem
You must be age 18 or older to be in this study. This study is not approved for the enrollment of people
under the age of 18
If you have questions, concerns, or complaints about this study or you want to get additional information
or provide input about this research, please contact Pooja N Mehta, RN BSN at 562-818-7484 or email at
pnmehta1128@gmail.com
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If you have questions about your rights as a research subject you may contact Susan Loess-Perez, DePaul
University’s Director of Research Compliance, in the Office of Research Services at 312-362-7593 or by
email at sloesspe@depaul.edu. You may also contact DePaul’s Office of Research Services if:
•! Your questions, concerns, or complaints are not being answered by the research team.!
•! You cannot reach the research team.!
•! You want to talk to someone besides the research team.!
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